arrow
J

Joel M. Gelfand

University of Pennsylvania
H指数:97
被引数:3.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bridging psoriasis and metabolic comorbidities: Toward comprehensive patient management. Priorities from the International Psoriasis Council

银屑病与代谢性合并症的联系:迈向全面的病人管理。国际银屑病委员会的优先事项

2026-07-250
OA
Impact of Online vs In-Person Management of Atopic Dermatitis on Quality of Life and Access to Care: A Randomized Controlled Trial

在线与面对面管理特应性皮炎对生活质量及医疗可及性的影响:一项随机对照试验

2026-06-260
PRE
Prevalence, multiterritorial vascular distribution, and burden of subclinical atherosclerosis in psoriasis: The EDSAP study

银屑病中临床前动脉粥样硬化的患病率、多地域血管分布及其负担:EDSAP研究

2026-01-012
OAAI
Joint Position Statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on Routine Testing for Latent Tuberculosis Infection Prior To and During Treatment of Psoriasis Patients with IL-17 or IL-23 Inhibitors

中华银屑病基金会医学委员会与国际银屑病委员会联合立场声明:关于在应用IL-17或IL-23抑制剂治疗银屑病患者前及治疗期间常规检测潜伏性结核感染的说明

2025-11-170
OAAI
Residual Inflammation in Patients with Psoriasis Treated with Biologic Therapy: Findings from 3 Prospective Observational Cohorts

生物制剂治疗银屑病患者的残余炎症:来自3个前瞻性观察队列的研究发现

2025-05-200
PRE
Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis
2024-12-011
PRE